ArticleBMJ case reports2021

Potential disease trigger as a therapeutic option: infliximab for paradoxical reaction in tuberculosis of the central nervous system.

Myriam Briner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.